Back

The predictive value of routine troponin measurements in patients treated with immune checkpoint inhibitors

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: How to improve prognosis in cardio-oncology Cardio-Oncology HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Michal Laufer-Perl

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

4 More presentations in this session

Presentation thumbnail
Cardiotoxicity in multiple myeloma patients in Hong Kong: a single-centre experience in the past decade
Doctor M. Ho (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Inherited cardiovascular disease mindset at cardio-oncology screening
Doctor R. Lorca (Oviedo, ES)
Abstract Slides Video
Presentation thumbnail
Soluble guanylate cyclase activator vericiguat prevents anthracycline-mediated cardiotoxicity and sarcopenia through NO-sGC-cGMP-NLRP3 pathway
Doctor N. Maurea (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study
Doctor A. Abiodun (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
How to improve prognosis in cardio-oncology
Video

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources